Contact Lens Spectrum

References

June 2013

Document #211



(p. 14) Prescribing for Astigmatism – Surgical Correction of Astigmatism, Part 1

By Jared Jaynes, OD, & Timothy B. Edrington, OD, MS, FAAO


Hartstein J. Review of Refraction. St. Louis: CV Mosby; 1971. Chapter 5, Astigmatism; p. 38.


Abrams D. Ophthalmic optics and refraction. In: Duke-Elder SS, ed. System of Ophthalmology, St. Louis: Mosby;1970:671-4


Wolffsohn JS, Bhogal G, Shah S. Effect of uncorrected astigmatism on vison. J Cataract Refract Surg 2011;37:454-460


Ivarsen A, Naeser K, Hjortdal J. Laser in situ keratomileusis for high astigmatism in myopic and hyperopic eyes. J Cataract Refract Surg 2013;39:74-80


Lee BS, Lindstrom RL, Reeves SW, Hardten DR. Modern management of astigmatism. International Ophthalmology Clinics 2013;53(1):65-78.



(p. 15) GP Insights – Utilizing Topography in Fitting Irregular Corneas

By Gregory W. DeNaeyer, OD, FAAO


Schornack MM, Patel SV. Relationship between corneal topographic indices and scleral lens base curve. Eye Contact Lens. 2010 Nov;26(6):330-3


Sindt CW, Grout TK, Kojima R. Evaluating virtual fitting for keratoconus. CL Spectrum. 2011 May.



(p. 17) Contact Lens Design & Materials – Material for SiHy Daily Disposable Makes U.S. Debut

By Neil Pence, OD, FAAO


Chin, J & C Riley. Fit Match of Current Acuvue 2 Wearers with Asian Eye Anatomy into Acuvue Oasys and Acuvue Advance. Scientific Poster, American Academy of Optometry Annual Meeting, October 25, 2007.



(p. 18) Dry Eye Dx and Tx – Test Driving a New Treatment

By Katherine M. Mastrota, MS, OD, FAAO


Lane SS, DuBiner HB, Epstein RJ, Ernest PH, Greiner JV, Hardten DR, Holland EJ, Lemp MA, McDonald JE 2nd, Silbert DI, Blackie CA, Stevens CA, Bedi R. A new system, the LipiFlow, for the treatment of meibomian gland dysfunction. Cornea. 2012 Apr;31(4):396-404.


Greiner JV. A single LipiFlow® Thermal Pulsation System treatment improves meibomian gland function and reduces dry eye symptoms for 9 months. Curr Eye Res. 2012 Apr;37(4):272-8.


Greiner JV. Long-term (12-month) improvement in meibomian gland function and reduced dry eye symptoms with a single thermal pulsation treatment. Clin Experiment Ophthalmol. 2012 Nov 13. [Epub ahead of print].



(p. 20) Understanding Contemporary Contact Lens Care Products

By Susan J. Gromacki, OD, MS, FAAO, & Michael A. Ward, MMSc, FAAO

Meadows D, Ketelson H, Schlitzer R et al. Soft contact lens care and patient education. In : Hom MM, Bruce AS, eds. Manual of Contact Lens Prescribing and Fitting. Butterworth, Heinemann, Elsevier 2006:363-372.

Carnt NA, Evans VE, Naduvilath TJ, et al. Contact lens-related adverse events and the Silicone Hydrogel lenses and daily wear care system used. Arch Ophthalmol 2009;127(12):1616-1623.

Andrasko G. www.StainGrid.com. Accessed April 1, 2013.

Green JA, Phillips KS, Hitchins VM, Lucas AD, Shoff ME, Hutter JC, Rorer EM, Eydelman MB. Material roperties that predict preservative uptake for Silicone Hydrogel contact lenses. Eye & Contact Lens 2012;38(6):350-357.

Harris JK.  Solutions for cleaning, disinfection and storage.  In: Aquavella JV, Rao G, eds. Contact Lenses.  Philadelphia: JB Lippincott, 1987:226-262.

Janoff LE.  The effective disinfection of soft contact lenses using hydrogen peroxide.  
Contact 1979;12:37-40.

Gromacki SJ. Hydrogen Peroxide contact lens disinfection, Part 1. Contact Lens Spectrum 2012;28(5):23.

Gromacki SJ. Hydrogen Peroxide contact lens disinfection, Part 2. Contact Lens Spectrum 2012;28(9):25.

Hutter JC, Green JA, Eydelman MB. Proposed Silicone Hydrogel contact lens grouping system for lens care product compatibility testing. Eye & Contact Lens 2012;38(6):358-362.


• Gromacki SJ. Prescribe the best solution for Silicone Hydrogel lenses. Optometric Management 2007;42(4):61-65.


• Gromacki SJ. Hydrogel and Silicone Hydrogel lens care. Contact Lens Spectrum 2008;22(2):26-32.


Nielsen MarketTrack data for Drug+ Grocery+ Mass Merchandiser retail sales: 52 Weeks ending December 31, 2012.

Gromacki SJ. The truth about generics. Contact Lens Spectrum 2005;20(12):24.

Davis J, Ketelson HA, Shows A, Meadows DL. A lens care solution designed for wetting silicone hydrogel materials. Presented at the Annual Research in Vision and Ophthalmology. Ft. Lauderdale, FL, May, 2010.

Ward MA. Recommendations for GP scleral lens care. Contact Lens Spectrum 2009;24 (3)


Ward MA. In defense of water: Another look at lenses and water. Contact Lens Spectrum 2009;24(5)


Ward MA. We need daily lens cleaners. Contact Lens Spectrum 2012;27(2)


Ward MA. Resolving GP surface-wetting problems CSI Style. Contact Lens Spectrum 2012;27(8):23.


www.Bausch.com; accessed April 4, 2013


Bennett ES, Grohe RM, Bornw MJ, et al. Resolving filmy Gas Permeable lenses; Part 1. Contact Lens Spectrum 2011;26(10)


Ward MA. Rewetting drops and dry eye. Review of Cornea and Contact Lenses. January 24, 2011.


Ward MA. GPC and GP lens care. Contact Lens Spectrum 2010;25(9)


Ward MA. An update on two GP lens care products. Contact Lens Spectrum 2010;25(5)


Sindt CW. Just in case, Review of Cornea and Contact Lenses 2012 (3);27


Ward MA. Choosing Piggyback lens care products. Contact Lens Spectrum 2006;21(1)


Ward MA. GP Contact lens care pearls. Contact Lens Spectrum 2012;27(10)


Ward MA. Contact lens rewetting drops. Refractive Eyecare 2009:11(16)


Ward, MA Wetting Approved for GP Lenses. Contact Lens Spectrum 2011 (1)


https://www.sclerallens.org; accessed April 4, 2013


http://www.fda.gov/medicaldevices/productsandmedicalprocedures/homehealthandconsumer/consumerproducts/contactlenses/ucm062584.htm; accessed April 7, 2013


http://www.contactlenses.org; accessed April 7, 2013


Olboeter N, Scholtz S. Case closed: A review of contact lens case care. Contact Lens Spectrum 2011;26(3)


Ahearn DG, Zhang S, Stulting D, et al. In vitro interactions of Fusarium and Acanthamoeba with drying residues of multipurpose contact lens solutions. Invest Ophthalmol Vis Sci 2011;52(3):1793-1799.


Shovlin JP. Acanthamoeba keratitis in rigid lens wearers: The issue of tap water rinses

International Contact Lens Clinic 1990;17(1,2):47-49.

                 

Ward MA. Contact lens care and compliance. Lens bacterial biofilm formation. Contact Lens Spectrum 2012;27(12)



(p. 34) Microbial Keratitis and Contact Lens Wear

By Katherine Weibel, OD; William L. Miller, OD, PhD, FAAO, & Jason J. Nichols, OD, MPH, PhD


Al-Badriyeh, D., Neoh, C. F., Stewart, K., and Kong, D. C. (2010). Clinical utility of voriconazole eye drops in ophthalmic fungal keratitis. Clin Ophthalmol 4, 391-405.

Alexandrakis, G., Alfonso, E. C., and Miller, D. (2000). Shifting trends in bacterial keratitis in south Florida and emerging resistance to fluoroquinolones. Ophthalmology 107, 1497-502.

Alfonso, E. C., Cantu-Dibildox, J., Munir, W. M., Miller, D., O'Brien, T. P., Karp, C. L., Yoo, S. H., Forster, R. K., Culbertson, W. W., Donaldson, K., Rodila, J., and Lee, Y. (2006). Insurgence of Fusarium keratitis associated with contact lens wear. Arch Ophthalmol 124, 941-7.

Asbell, P. A., Colby, K. A., Deng, S., McDonnell, P., Meisler, D. M., Raizman, M. B., Sheppard, J. D., Jr., and Sahm, D. F. (2008). Ocular TRUST: nationwide antimicrobial susceptibility patterns in ocular isolates. Am J Ophthalmol 145, 951-958.

Bourcier, T., Thomas, F., Borderie, V., Chaumeil, C., and Laroche, L. (2003). Bacterial keratitis: predisposing factors, clinical and microbiological review of 300 cases. Br J Ophthalmol 87, 834-8.

Cavanagh, H. D. (2007). Acanthamoeba keratitis: 2007: a train wreck in slow motion. Eye Contact Lens 33, 209.

Cavanagh, H. D., Jester, J. V., Essepian, J., Shields, W., and Lemp, M. A. (1990). Confocal microscopy of the living eye. CLAO J 16, 65-73.

Cheng, K. H., Leung, S. L., Hoekman, H. W., Beekhuis, W. H., Mulder, P. G., Geerards, A. J., and Kijlstra, A. (1999). Incidence of contact-lens-associated microbial keratitis and its related morbidity. Lancet 354, 181-5.

Constantinou, M., Daniell, M., Snibson, G. R., Vu, H. T., and Taylor, H. R. (2007). Clinical efficacy of moxifloxacin in the treatment of bacterial keratitis: a randomized clinical trial. Ophthalmology 114, 1622-9.

Dart, J. K., Saw, V. P., and Kilvington, S. (2009). Acanthamoeba keratitis: diagnosis and treatment update 2009. Am J Ophthalmol 148, 487-499 e2.

Garduno-Vieyra, L., Gonzalez-Sanchez, C. R., and Hernandez-Da Mota, S. E. (2011). Ultraviolet-a light and riboflavin therapy for acanthamoeba keratitis: a case report. Case Report Ophthalmol 2, 291-5.

Garg, P., Sharma, S., and Rao, G. N. (1999). Ciprofloxacin-resistant Pseudomonas keratitis. Ophthalmology 106, 1319-23.

Ibrahim, Y. W., Boase, D. L., and Cree, I. A. (2007). Factors affecting the epidemiology of Acanthamoeba keratitis. Ophthalmic Epidemiol 14, 53-60.

Kaye, S., Tuft, S., Neal, T., Tole, D., Leeming, J., Figueiredo, F., Armstrong, M., McDonnell, P., Tullo, A., and Parry, C. (2010). Bacterial susceptibility to topical antimicrobials and clinical outcome in bacterial keratitis. Invest Ophthalmol Vis Sci 51, 362-8.

Keay, L., Edwards, K., Naduvilath, T., Taylor, H. R., Snibson, G. R., Forde, K., and Stapleton, F. (2006). Microbial keratitis predisposing factors and morbidity. Ophthalmology 113, 109-16.

Khan, Y. A., Kashiwabuchi, R. T., Martins, S. A., Castro-Combs, J. M., Kalyani, S., Stanley, P., Flikier, D., and Behrens, A. (2011). Riboflavin and ultraviolet light a therapy as an adjuvant treatment for medically refractive Acanthamoeba keratitis: report of 3 cases. Ophthalmology 118, 324-31.

Khor, W. B., Aung, T., Saw, S. M., Wong, T. Y., Tambyah, P. A., Tan, A. L., Beuerman, R., Lim, L., Chan, W. K., Heng, W. J., Lim, J., Loh, R. S., Lee, S. B., and Tan, D. T. (2006). An outbreak of Fusarium keratitis associated with contact lens wear in Singapore. JAMA 295, 2867-73.

Makdoumi, K., Mortensen, J., and Crafoord, S. (2010). Infectious keratitis treated with corneal crosslinking. Cornea 29, 1353-8.

Mantopoulos, D., Cruzat, A., and Hamrah, P. (2010). In vivo imaging of corneal inflammation: new tools for clinical practice and research. Semin Ophthalmol 25, 178-85.

Martins, S. A., Combs, J. C., Noguera, G., Camacho, W., Wittmann, P., Walther, R., Cano, M., Dick, J., and Behrens, A. (2008). Antimicrobial efficacy of riboflavin/UVA combination (365 nm) in vitro for bacterial and fungal isolates: a potential new treatment for infectious keratitis. Invest Ophthalmol Vis Sci 49, 3402-8.

Niederer, R. L., and McGhee, C. N. (2010). Clinical in vivo confocal microscopy of the human cornea in health and disease. Prog Retin Eye Res 29, 30-58.

Pachigolla, G., Blomquist, P., and Cavanagh, H. D. (2007). Microbial keratitis pathogens and antibiotic susceptibilities: a 5-year review of cases at an urban county hospital in north Texas. Eye Contact Lens 33, 45-9.

Poggio, E. C., Glynn, R. J., Schein, O. D., Seddon, J. M., Shannon, M. J., Scardino, V. A., and Kenyon, K. R. (1989). The incidence of ulcerative keratitis among users of daily-wear and extended-wear soft contact lenses. N Engl J Med 321, 779-83.

Pradhan, L., Sharma, S., Nalamada, S., Sahu, S. K., Das, S., and Garg, P. (2011). Natamycin in the treatment of keratomycosis: correlation of treatment outcome and in vitro susceptibility of fungal isolates. Indian J Ophthalmol 59, 512-4.

Schaumberg, D. A., Snow, K. K., and Dana, M. R. (1998). The epidemic of Acanthamoeba keratitis: where do we stand? Cornea 17, 3-10.

Shah, V. M., Tandon, R., Satpathy, G., Nayak, N., Chawla, B., Agarwal, T., Sharma, N., Titiyal, J. S., and Vajpayee, R. B. (2010). Randomized clinical study for comparative evaluation of fourth-generation fluoroquinolones with the combination of fortified antibiotics in the treatment of bacterial corneal ulcers. Cornea 29, 751-7.

Spoerl, E., Mrochen, M., Sliney, D., Trokel, S., and Seiler, T. (2007). Safety of UVA-riboflavin cross-linking of the cornea. Cornea 26, 385-9.

Srinivasan, M., Mascarenhas, J., and Prashanth, C. N. (2008). Distinguishing infective versus noninfective keratitis. Indian J Ophthalmol 56, 203-7.

Stapleton, F., Keay, L., Edwards, K., Naduvilath, T., Dart, J. K., Brian, G., and Holden, B. A. (2008). The incidence of contact lens-related microbial keratitis in Australia. Ophthalmology 115, 1655-62.

Sueke, H., Kaye, S., Neal, T., Murphy, C., Hall, A., Whittaker, D., Tuft, S., and Parry, C. (2010). Minimum inhibitory concentrations of standard and novel antimicrobials for isolates from bacterial keratitis. Invest Ophthalmol Vis Sci 51, 2519-24.

Thomas, P. A., and Geraldine, P. (2007). Infectious keratitis. Curr Opin Infect Dis 20, 129-41.

Tu, E. Y., and Joslin, C. E. (2010). Recent outbreaks of atypical contact lens-related keratitis: what have we learned? Am J Ophthalmol 150, 602-608 e2.

Verani, J. R., Lorick, S. A., Yoder, J. S., Beach, M. J., Braden, C. R., Roberts, J. M., Conover, C. S., Chen, S., McConnell, K. A., Chang, D. C., Park, B. J., Jones, D. B., Visvesvara, G. S., and Roy, S. L. (2009). National outbreak of Acanthamoeba keratitis associated with use of a contact lens solution, United States. Emerg Infect Dis 15, 1236-42.

Willcox, M. D. (2012). Management and treatment of contact lens-related Pseudomonas keratitis. Clin Ophthalmol 6, 919-24.

Wollensak, G., Spoerl, E., and Seiler, T. (2003). Stress-strain measurements of human and porcine corneas after riboflavin-ultraviolet-A-induced cross-linking. J Cataract Refract Surg 29, 1780-5.

Wong, R. L., Gangwani, R. A., Yu, L. W., and Lai, J. S. (2012). New treatments for bacterial keratitis. J Ophthalmol 2012, 831502.

Zhivov, A., Stachs, O., Kraak, R., Stave, J., and Guthoff, R. F. (2006). In vivo confocal microscopy of the ocular surface. Ocul Surf 4, 81-93.


(p. 42) Contact Lens Practice Pearls – For Comfortable Lens Wear, Start With the Ocular Surface

By Jason R. Miller, OD, MBA, FAAO


1. Sutphin JE, et al. Basic clinical science course: external disease and cornea. Section 8. American Academy of Ophthalmology,2006-2007:20-2.


2. Rashid S, Jin Y, Ecoiffier T, et al. Topical omega-3 and omega-6 fatty acids for treatment of dry eye. Arch Ophthalmol 2008 Feb;126(2):219-25.


(p. 47) Treatment Plan – Is Off-Label Prescribing Going to Get Easier?

By Leo Semes, OD, FAAO


1. http://www.nytimes.com/2012/12/19/business/amgen-agrees-to-pay-762-million-in-drug-case.html?_r=0 Accessed February 17, 2013


2. http://www.justice.gov/opa/pr/2012/July/12-civ-842.html Accessed February 17, 2013


3.http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM075082.pdf Accessed February 17, 2013


4. U. S. v. Caronia. 09-5006-CR (http://www.


5. Boumil MM. Off-label marketing and the first amendment. N Engl J Med. 2013; 368: 103-5.


(p. 50) Reader and Industry Forum – A New Method for Determining Toric Lens Rotation

By Ane Murueta-Goyena Larrañaga




End Document #211